Midday movers: Lowe's and Zoom rise; Unity Software falls
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
TD Cowen Downgrades Macy's (M) to Market Perform, 'Prudent Bold New Changes Will Take Time to Drive Upside to Guidance'
February 29, 2024 5:29 AM ESTTD Cowen analyst Oliver Chen downgraded Macy's (NYSE: M) from Outperform to Market Perform with a price target of $20.00 (from $23.00).
The analyst comments "We like changes ahead including 150 Macy's closures, store growth across luxury (+30 Bluemercury & +15 Bloomies) and small format (+30), and private label and inventory... More
Macy's (M) PT Raised to $22 at Citi, 'We Lean More Positive but Stay Neutral'
February 28, 2024 3:19 AM ESTCiti analyst Paul Lejuez raised the price target on Macy's (NYSE: M) to $22.00 (from $18.00) while maintaining a Neutral rating.
The analyst comments "4Q GM/EPS beat consensus though sales were still weak (comps -5%) and mgmt is looking for a sales decline in... More
CFRA Downgrades Macy's (M) to Hold
February 27, 2024 12:55 PM ESTCFRA analyst Zachary Warring downgraded Macy's (NYSE: M) from Buy to Hold with a price target of $18.00 (from $19.00).
The analyst comments "We lower our 12-month price target by $1 to $18, based on 7.2x our FY 25 (Jan.) EPS estimate and in line with the company's... More
Viking Therapeutic (VKTX) PT Raised to $80 at Stifel, '“Best-in-Class” Profile of Injectable VK2735 Stands Firm'
February 27, 2024 12:06 PM ESTStifel analyst Samimy Annabel raised the price target on Viking Therapeutic (NASDAQ: VKTX) to $80.00 (from $35.00) while maintaining a Buy rating.
The analyst comments "Ahead of schedule, VKTX released the Ph.2 VENTURE data for injectable-VK2735, which again demonstrated a highly competitive profile relative to... More
AutoZone (AZO) PT Raised to $3,200 at CFRA, 'We...like AZO's robust international growth'
February 27, 2024 12:04 PM ESTCFRA analyst Garrett Nelson raised the price target on AutoZone (NYSE: AZO) to $3,200.00 (from $3,000.00) while maintaining a Buy rating.
The analyst comments "We lift our 12-month target to $3,200 from $3,000, based on a FY 25 (Aug.) P/E of 19.0x, a premium to... More



